TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity-Reference-Cited by-同舟云学术

TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity

Published:2009-05 Issue:23 Volume:27 Page:3045-3052
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Johnson Teresa R.,Rao Srinivas,Seder Robert A.,Chen Man,Graham Barney S.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference57 articles.

1. Palivizumab in the prophylaxis of respiratory syncytial virus infection;Cardenas;Expert Rev Anti Infect Ther,2005

2. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants;Karron;J Infect Dis,2005

3. Toll-like receptors and innate immunity;Medzhitov;Nature Rev Immunol,2001

4. Toll-like receptor and RIG-I-like receptor signaling;Kawai;Ann NY Acad Sci,2008

5. Toll-like receptors, transduction-effector pathways, and disease diversity: evidence of an immunobiological paradigm explaining all human illness?;Atkinson;Int Rev Immunol,2008

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection;Expert Review of Anti-infective Therapy;2024-09-13

2. Immunoprophylaxis of Respiratory Syncytial Virus Infection: Recent Updates;Indian Journal of Respiratory Care;2024-04-06

3. Immunogenicity of Recombinant Lipid-Based Nanoparticle Vaccines: Danger Signal vs. Helping Hand;Pharmaceutics;2023-12-23

4. The effect of Toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice;Frontiers in Cellular and Infection Microbiology;2023-10-03

5. Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses;Nature Communications;2023-06-22